SecBot SecBot

YDESW

YD Bio Ltd
Nasdaq· Services-Medical Laboratories· Inc. E9· CIK 0002011674 Healthcare & Medical Devices
Warrants of YD Bio Ltd · YDES stock page →
—
Market cap
$32.6M
Nano cap
1 year
−64.5%
from $17.11 · Oct 27
30 days
−14.6%
from $7.11
52-week range
$1.90–17.11
−65% from high · low Jul 2
Avg volume 20D
170.6K
Oct 2 spike 546.6K
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 2 reports · latest
Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/2
Strongest BEARISH YD Bio's FY2025 annual report reveals a net loss of $8.3M on revenue of $597K, with operating expenses…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • TrendUPTREND

    21% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
Merit Financial Group, LLCTRIM19,239$6.0K

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 30, 2026 Inst.
Merit Financial Group, LLC — TRIM
19,239 shares ($6.0K)
Jun 1, 2026 SEC
The SEC declared effective a registration statement (File No. 333-290471) filed by YD Bio Ltd under the Securities Act…
EFFECT — Impact 4/10
Apr 30, 2026 SEC
YD Bio's FY2025 annual report reveals a net loss of $8.3M on revenue of $597K, with operating expenses surging 236% to…
20-F — Impact 7/10

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 neutral
All YDESW filing & press-release reports (2)